Skip to main content
Virologica Sinica logoLink to Virologica Sinica
. 2025 Nov 27;40(6):1066–1067. doi: 10.1016/j.virs.2025.10.002

Corrigendum to “Insights into recent advancements in human and animal rotavirus vaccines: Exploring new frontiers” [Virol. Sin. 40 (2025) 1–14]

Ahmed H Ghonaim a,b,c, Sherin R Rouby d, Wedad M Nageeb e, Ashraf Ahmed Elgendy f, Rong Xu a,b, Changsheng Jiang g, Noha H Ghonaim h, Qigai He a,b,i, Wentao Li a,b,i,⁎
PMCID: PMC12826949  PMID: 41314928

The original version of Figure 2 contained the following inaccuracies: Rotarix was incorrectly shown as a 3-dose vaccine instead of a 2-dose vaccine; RotaTeq and Rotasiil were incorrectly shown as 2-dose vaccines instead of 3-dose vaccines; Polyvac was incorrectly shown as a 3-dose vaccine instead of a 2-dose regimen; and the LLR vaccine should have been indicated as a single primary dose followed by annual boosters between 2 months and 3 years of age.

The corrected Fig. 2 is presented below. We apologize for our oversight in the preparation of the figure and state that this does not change the scientific conclusions of the article in any way.

Image 1


Articles from Virologica Sinica are provided here courtesy of Wuhan Institute of Virology, Chinese Academy of Sciences

RESOURCES